Replies to post #743694 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Droid,

Thanks for reposting your opinion again 😶

Yes, Linda is “on her plan” and yes, “it is working.”



✅️ It was her plan to acquire, develop, and secure a valuable patent-fortified manufacturing technology called EDEN. (Flaskworks strategic acquisition was relatively recent in 2020).

✅️ It was her plan to get a prestigious and reputable medical journal to publish an independently peer-reviewed analysis of the P3.

✅️ It was her plan to acquire the commercial rights to a SECOND patent-fortified novel dendritic cell technology that’s in PII trials funded by the U.S. DoD at Roswell Park.

✅️ It was her plan to recruit Linda Liau to join the SAB at NWBO.

✅️ It was her plan to secure a PIP approval and an MIA approval from MHRA followed by a voluminous MAA submission.

✅️ It was her plan to recruit Dr. Ashkan to run the DCVax-L trial in Europe and lead the UK Specials Program that has the ongoing support of the MHRA.




“His work on brain cancer vaccines received the top presentation award by the British Neuro-Oncology Society in 2022 and promises to impact the care of patients with brain tumours worldwide.”

Consultant Neurosurgeon at @KingsCollegeNHS, Professor Keyoumars Ashkan, receives an MBE for services to neurosurgery.
 
In 2020, he removed patient Dagmar's brain tumour while she played her violin throughout the surgery. 👇pic.twitter.com/H2Z4LZic0h

— NHS London (@NHSEnglandLDN) December 31, 2024

https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.xml

https://www.kcl.ac.uk/news/professor-keyoumars-ashkan-awarded-mbe-in-kings-new-years-honours

https://www.bbc.com/news/uk-england-london-66378288